Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DB-020 for prevention of cisplatin-induced ototoxicity
NCT04262336Phase 1Completed
- Sponsor
- Decibel Therapeutics
- Start
- Feb 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of sodium thiosulfate in ototoxicity (2 cohorts), sponsored by Decibel Therapeutics. Primary endpoint: Treatment-Emergent Adverse Events. Started Feb 2020; status: completed.
02
Drugs
sodium thiosulfate
03
Conditions
ototoxicity
Beyond the preview
Go deeper on NCT04262336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04262336.